Q4 2023 Quoin Pharmaceuticals Ltd Earnings Call Transcript
Good day, and welcome to the Quoin Pharmaceuticals' fourth-quarter financial results and business update conference call. (Operator Instructions) Please note, today's event is being recorded.
I would now like to turn the conference over to Gordon Dunn, Chief Financial Officer. Please go ahead, sir.
Thank you, and good morning. We appreciate you joining us on today's conference call.
With me on the call are Dr. Michael Myers, CEO; and Denise Carter, COO. We're pleased to provide an update on our progress for the fourth quarter of 2023 as well as discussing our Q4 and full-year 2023 financial results. Please note that our operations and financial results press release is now available on our website.
In keeping with normal procedure, Michael will first provide an operations update, following which I will review our financial results. I will then hand the call back to Michael for closing comments before we open the phone lines for questions.
I'd like to remind everyone that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |